Gradually, the differences in clinical presentation from NF1, led to the labelling of NF2-SWN as bilateral acoustic or central neurofibromatosis based primarily on work at the National Institutes of Health (NIH) in Maryland USA [10, 11]. The gene discussed is NF2; the disease is neurofibromatosis.